Charlotte's Web Holdings, Inc. (CWBHF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Charlotte's Web Holdings, Inc. (CWBHF) trades at $0.32 with AI Score 51/100 (Grade B). Charlotte's Web Holdings, Inc. focuses on producing and distributing hemp-derived cannabidiol (CBD) wellness products. Market cap: $51.25M, Sector: Healthcare.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for CWBHF: CWBHF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CWBHF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
CWBHF: 2/7 perspectives are bullish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Charlotte's Web Holdings, Inc. (CWBHF) Healthcare & Pipeline Overview
Charlotte's Web Holdings, Inc. cultivates, manufactures, and distributes hemp-derived CBD wellness products, including tinctures, gummies, and topicals, targeting both human and pet markets through retail and online channels, while navigating a complex regulatory landscape in the specialty drug sector.
What Is the Investment Thesis for CWBHF?
Charlotte's Web Holdings, Inc. operates in the evolving CBD wellness market. The company's diverse product portfolio and established brand presence are key value drivers. Growth catalysts include expanding retail partnerships and continued product innovation. However, the company faces risks related to regulatory uncertainty and competition within the CBD industry. With a market capitalization of $51.25M and a negative P/E ratio of -4.57, the company's profitability remains a concern. Investors should monitor the company's ability to achieve profitability and navigate the regulatory landscape to capitalize on the growing demand for CBD products. The company's gross margin of 44.3% indicates potential for improved profitability with scale.
Based on FMP financials and quantitative analysis
CWBHF Key Highlights
- Market capitalization of $51.25M reflects the company's current valuation in the competitive CBD market.
- Gross margin of 44.3% indicates the company's ability to generate revenue from its products after accounting for the cost of goods sold.
- Negative P/E ratio of -4.57 suggests the company is currently unprofitable, requiring further analysis of its financial performance.
- The company's beta of 2.41 indicates higher volatility compared to the overall market, suggesting a riskier investment.
- The company's collaboration with the University at Buffalo and McLean Hospital highlights its commitment to research and development in the CBD space.
Who Are CWBHF's Competitors?
CWBHF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AVCNF Avicanna Inc. | $0.08 | -6.78% | $10.38M | 52 |
| CNTMF Fluent Corp. | $0.02 | -0.80% | $10.45M | 45 |
| FNCH Finch Therapeutics Group, Inc. | $8.70 | +16.00% | $13.97M | — |
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CWBHF's Key Strengths?
- Established brand recognition
- Diverse product portfolio
- Strong distribution network
- Commitment to research and development
What Are CWBHF's Weaknesses?
- Negative profitability
- High beta indicating volatility
- Dependence on evolving regulatory landscape
- Intense competition in the CBD market
What Could Drive CWBHF Stock Higher?
- Expansion of retail partnerships to increase product distribution and market reach.
- Product innovation and diversification to cater to evolving consumer preferences and health needs.
- Potential regulatory changes in the CBD industry that could impact market access and product labeling.
- Research and development efforts to validate the efficacy and safety of CBD products.
- International expansion initiatives to tap into new markets and revenue streams.
What Are the Key Risks for CWBHF?
- Financial-distress signal — its Altman Z-Score of -6.37 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Regulatory uncertainty and evolving legal landscape surrounding CBD products.
- Intense competition from other CBD manufacturers and distributors.
- Fluctuations in hemp prices and supply chain disruptions.
- Changing consumer preferences and market trends.
- Negative publicity or adverse events related to CBD products.
What Are the Growth Opportunities for CWBHF?
- Expansion of Retail Partnerships: Charlotte's Web can drive growth by expanding its distribution network through partnerships with major retailers. The increasing acceptance of CBD products in mainstream retail channels presents a significant opportunity to reach a broader customer base. Securing shelf space in national chains and regional retailers can significantly boost sales volume and brand visibility. The timeline for realizing this growth opportunity is immediate and ongoing, as the company continues to pursue and cultivate retail partnerships. This strategy leverages the growing market demand for accessible CBD products.
- Product Innovation and Diversification: Investing in research and development to create new and innovative CBD products can drive growth. Developing targeted formulations for specific health conditions, such as sleep, stress, and pain management, can attract new customers and increase market share. Expanding the product line to include novel delivery methods, such as transdermal patches or inhalers, can also differentiate Charlotte's Web from competitors. The timeline for this growth opportunity is medium-term, requiring ongoing investment in R&D and clinical trials. The potential market size for targeted CBD formulations is substantial, driven by the increasing demand for personalized wellness solutions.
- Strategic Acquisitions and Partnerships: Acquiring complementary businesses or forming strategic partnerships can accelerate growth and expand market reach. Acquiring smaller CBD brands with unique product offerings or established customer bases can provide access to new markets and distribution channels. Partnering with pharmaceutical companies or healthcare providers can facilitate the development and commercialization of cannabinoid-based therapies. The timeline for this growth opportunity is medium to long-term, requiring careful evaluation of potential targets and partners. The potential market size for cannabinoid-based therapies is significant, driven by the increasing interest in natural alternatives to traditional pharmaceuticals.
- International Expansion: Expanding into international markets can drive growth by tapping into new customer bases and revenue streams. The global CBD market is growing rapidly, with significant opportunities in Europe, Asia, and Latin America. Adapting product formulations and marketing strategies to meet local regulations and consumer preferences is crucial for success. The timeline for this growth opportunity is long-term, requiring careful planning and execution. The potential market size for CBD products in international markets is substantial, driven by the increasing global awareness of CBD's potential health benefits.
- Direct-to-Consumer (DTC) Channel Optimization: Enhancing the company's online presence and DTC capabilities can drive growth by increasing customer engagement and sales. Investing in website optimization, digital marketing, and customer relationship management (CRM) can improve the customer experience and drive conversions. Offering personalized product recommendations, subscription services, and loyalty programs can increase customer retention and lifetime value. The timeline for this growth opportunity is immediate and ongoing, as the company continuously refines its DTC strategy. The potential market size for online CBD sales is significant, driven by the increasing trend of online shopping and the convenience of DTC channels.
What Opportunities Does CWBHF Have?
- Expansion of retail partnerships
- Product innovation and diversification
- Strategic acquisitions and partnerships
- International expansion
What Threats Does CWBHF Face?
- Regulatory uncertainty
- Increased competition
- Fluctuations in hemp prices
- Changing consumer preferences
What Are CWBHF's Competitive Advantages?
- Established brand recognition and reputation in the CBD market.
- Proprietary hemp genetics and cultivation practices.
- Diverse product portfolio catering to various customer needs.
- Strong distribution network through retail, online, and healthcare channels.
What Does CWBHF Do?
Founded in 2013 and headquartered in Denver, Colorado, Charlotte's Web Holdings, Inc. emerged as a prominent player in the burgeoning hemp-derived CBD market. Originally known as Stanley Brothers Holdings Inc., the company rebranded in 2018 to Charlotte's Web Holdings, Inc. The company's origins are rooted in providing CBD products to individuals seeking natural wellness solutions. Charlotte's Web cultivates hemp and manufactures a range of CBD products, including hemp extract oil tinctures, gummies, capsules, and topical creams and lotions. These products are marketed under the Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp brands. The company's products contain phytocannabinoids, including CBD, cannabichromene, cannabigerol, and cannabinol, along with terpenes and flavonoids. Charlotte's Web distributes its products through retail outlets, healthcare practitioners, and its online platform. The company also engages in research and development through its CW Labs division, collaborating with institutions like the University at Buffalo and McLean Hospital to advance hemp cannabinoid science.
What Products and Services Does CWBHF Offer?
- Cultivates hemp plants for CBD extraction.
- Manufactures hemp-derived CBD wellness products.
- Produces CBD oil tinctures, gummies, capsules, and topicals.
- Markets products under the Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp brands.
- Distributes products through retail outlets, healthcare practitioners, and online.
- Conducts research and development to advance hemp cannabinoid science.
- Collaborates with universities and hospitals on research programs.
How Does CWBHF Make Money?
- Cultivates hemp and extracts CBD.
- Manufactures and sells CBD products through various channels.
- Generates revenue through retail sales, online sales, and partnerships.
- Invests in research and development to innovate and improve products.
What Industry Does CWBHF Operate In?
Charlotte's Web Holdings, Inc. operates within the rapidly growing CBD market, driven by increasing consumer awareness and acceptance of CBD products for wellness purposes. The industry is characterized by intense competition, evolving regulations, and varying product quality standards. Charlotte's Web differentiates itself through its established brand, diverse product portfolio, and commitment to research and development. The company competes with other CBD manufacturers and distributors, as well as pharmaceutical companies exploring cannabinoid-based therapies. Navigating the regulatory landscape and ensuring product quality are critical for success in this dynamic market.
Who Are CWBHF's Key Customers?
- Individuals seeking natural wellness solutions.
- Retail consumers purchasing CBD products online and in stores.
- Healthcare practitioners recommending CBD products to patients.
- Pet owners seeking CBD products for their pets.
Company Profile
Charlotte's Web Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Louisville, US. The company is led by CEO Marcel Bonn-Miller. CWBHF has traded publicly since 2018.
F-Score 3/9Financial Health
Charlotte's Web Holdings, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -6.37 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on assets is -51.8%, showing how much profit it generates from its asset base. Its free cash flow yield is -31.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.35 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -81.1%, the inverse of the P/E and a quick read on earnings relative to price.
CWBHF Valuation & Market Position
With a $51.25M market cap, Charlotte's Web Holdings, Inc. sits in the micro-cap segment of the market. Relative to its peer group, CWBHF's quantitative score of 51/100 is roughly in line with the peer average of 59/100.
FY2026 estForward Outlook
Wall Street analysts project Charlotte's Web Holdings, Inc. revenue of about $47.9M for fiscal 2026, with EPS near $-0.15.
CWBHF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Established brand recognition
- Diverse product portfolio
- Strong distribution network
- Commitment to research and development
Bear Case
- Negative profitability
- High beta indicating volatility
- Dependence on evolving regulatory landscape
- Intense competition in the CBD market
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
CWBHF Latest News
-
Charlotte's Web First Quarter 2026 Financial Results
TMX Newsfile · May 13, 2026
-
Stocks That Hit 52-Week Lows On Tuesday
· Feb 11, 2020
CWBHF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CWBHF.
Price Targets
Wall Street price target analysis for CWBHF.
CWBHF MoonshotScore
What does this score mean?
The MoonshotScore rates CWBHF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: William J. Morachnick
CEO
William J. Morachnick serves as the CEO of Charlotte's Web Holdings, Inc. His background includes extensive experience in consumer packaged goods and retail industries. Prior to joining Charlotte's Web, he held leadership positions at various companies, focusing on strategic planning, operations, and business development. His expertise spans across multiple functional areas, including sales, marketing, and supply chain management. He is responsible for overseeing the company's overall strategy and operations.
Track Record: Since assuming the role of CEO, William J. Morachnick has focused on driving revenue growth, improving operational efficiency, and navigating the evolving regulatory landscape. He has overseen the expansion of the company's product portfolio and distribution network. Key milestones under his leadership include strategic partnerships and investments in research and development. He manages 112 employees.
CWBHF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Charlotte's Web Holdings, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Potential for price manipulation and fraud.
- Lower trading volumes and liquidity.
- Higher bid-ask spreads.
- Increased regulatory scrutiny.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review the company's OTC Markets profile and disclosure statements.
- Consult with a financial advisor to assess the risks and potential rewards.
- Check for any regulatory actions or legal proceedings involving the company.
- Understand the company's capital structure and ownership.
- Established brand presence in the CBD market.
- Partnerships with reputable retailers and healthcare providers.
- Commitment to research and development.
- Active management team with relevant industry experience.
- Publicly available information and disclosures (if any).
CWBHF Healthcare Stock FAQ
What does Charlotte's Web Holdings, Inc. do?
Charlotte's Web Holdings, Inc. is a vertically integrated company that cultivates hemp and manufactures hemp-derived CBD wellness products. The company's product portfolio includes CBD oil tinctures, gummies, capsules, and topicals marketed under the Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp brands. These products are distributed through retail outlets, healthcare practitioners, and the company's online platform. Charlotte's Web focuses on providing natural wellness solutions to consumers and pets, while also investing in research and development to advance hemp cannabinoid science.
What are the main risks for CWBHF?
Charlotte's Web Holdings, Inc. faces several risks, including regulatory uncertainty, intense competition, fluctuations in hemp prices, and changing consumer preferences. The evolving legal landscape surrounding CBD products poses a significant risk, as changes in regulations could impact market access and product labeling. Increased competition from other CBD manufacturers and distributors could erode market share and pricing power. Fluctuations in hemp prices and supply chain disruptions could impact the company's cost of goods sold and profitability. Changing consumer preferences and market trends could require the company to adapt its product offerings and marketing strategies.
What are the key factors to evaluate for CWBHF?
Charlotte's Web Holdings, Inc. (CWBHF) holds an AI score of 51/100 (moderate). Not financial advice.
How frequently does CWBHF data refresh on this page?
CWBHF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CWBHF's recent stock price performance?
Charlotte's Web Holdings, Inc. (CWBHF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand recognition. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CWBHF overvalued or undervalued right now?
Valuing Charlotte's Web Holdings, Inc. (CWBHF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CWBHF?
Before investing in Charlotte's Web Holdings, Inc. (CWBHF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding CWBHF to a portfolio?
Key strength of Charlotte's Web Holdings, Inc. (CWBHF): Established brand recognition. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited or delayed.